EUVIMEDEUVIMED entdecken
Crossref

Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma

Kazuya Koyama, Kenji Takahashi iD, Yusuke Ono, Kyohei Oyama, Nobue Tamamura, Hiroki Tanaka, Fumi Asai, Yukino Kobayashi, Chiho Maeda, Yu Ohtaki, Hiroki Sato, Tetsuhiro Okada und 11 weitere

Journal of Gastroenterology · 2026-05 · 61 (5) · 660-672

DOI: 10.1007/s00535-026-02382-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 10.03.2026. Verfasst von Kazuya Koyama und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Asahikawa Medical University, 2-1-1-1, Midorigaoka Higashi, Asahikawa, Hokkaido, 078-8510, Japa…. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Pancreatic Ductal, Biomarkers, Tumor, Pancreatic Neoplasms. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Pancreas Research Foundation of Japan, Japanese Society of Gastroenterology Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: MicroRNAs (miRNAs) enclosed within extracellular vesicles (EVs) have emerged as crucial players in carcinogenesis and are increasingly recognized as potential cancer biomarkers. However, their significance in pancreatic ductal adenocarcinoma (PDAC) and their utility for early detection remain unclear. METHODS: We utilized microarray analysis to identify the miRNAs highly expressed in PDAC cells compared to immortalized pancreatic ductal cells. Functional studies investigated the effect of miRNA overexpression and inhibition on PDAC cells invasion/migration and associated signaling pathways. Additionally, we examined the transfer of miRNA via EVs and their potential impact on the recipient PDAC cells. Serum samples from 30 healthy individuals, 30 patients with intraductal papillary mucinous neoplasm, and 30 PDAC were analyzed for EV miRNA expression using digital PCR. RESULTS: MiR-425 emerged as an oncogenic miRNA upregulated in PDAC, suppressing phosphatase and tensin homolog (PTEN) while activating phosphatidylinositol 3-kinase (PI3K)/Akt and epithelial-to-mesenchymal transition (EMT) pathways. Treatment with miR-425-enriched EVs induced EMT in PDAC cells by suppressing PTEN, enhancing invasion and migration. Serum EV miR-425 levels tended to be higher in PDAC patients, particularly in Stage I/II compared to Stage III/IV, although the difference was not statistically significant. Combining EV miR-425 with CA19-9 improved diagnostic performance over CA19-9 alone, achieving a sensitivity 93%, specificity 91%, and AUC of 0.98. CONCLUSION: Our finding suggested the role of intercellular transfer of EV miR-425 in inducing EMT via PTEN/PI3K/Akt pathway modulation, thereby promoting invasion and migration of PDAC cells. Serum EV miR-425 holds promise as a potential biomarker for early diagnosis of PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCarcinoma, Pancreatic DuctalBiomarkers, TumorPancreatic NeoplasmsExtracellular VesiclesHumansFemaleMaleMiddle AgedCell Line, TumorPTEN PhosphohydrolaseAgedEpithelial-Mesenchymal TransitionCell MovementNeoplasm InvasivenessSignal TransductionUp-RegulationEarly Detection of CancerGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

EMTExtracellular vesiclesLiquid biopsyMicroRNAPancreatic ductal adenocarcinoma

Substanzen

MicroRNAsBiomarkers, TumorMIRN425 microRNA, humanPTEN PhosphohydrolasePTEN protein, human

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, Asahikawa Medical University, 2-1-1-1, Midorigaoka Higashi, Asahikawa, Hokkaido, 078-8510, Japan.
  • Division of Gastroenterology, Department of Medicine, Asahikawa Medical University, 2-1-1-1, Midorigaoka Higashi, Asahikawa, Hokkaido, 078-8510, Japan. t-kenji@asahikawa-med.ac.jp.
  • Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan. t-kenji@asahikawa-med.ac.jp.
  • Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Hokkaido, Japan.
  • Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.

ORCID-Profile: Kenji Takahashi

Förderung

  • Japan Society for the Promotion of Science
  • Pancreas Research Foundation of Japan
  • Japanese Society of Gastroenterology Grant
  • Princess Takamatsu Cancer Research Fund
  • The Naito Grant for the advancement of natural science
  • Project Mirai Cancer Research Grants

Zitieren

APA

Koyama, K., Takahashi, K., Ono, Y., Oyama, K., Tamamura, N., Tanaka, H., Asai, F., Kobayashi, Y., Maeda, C., Ohtaki, Y., Sato, H., Okada, T., Kawabata, H., Iwamoto, H., Kitano, Y., Itoh, T., Matsuda, A., Inuzuka, T., Taniue, K., …, & Mizukami, Y. (2026). Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma. Journal of Gastroenterology, 61(5), 660-672. https://doi.org/10.1007/s00535-026-02382-9

Vancouver

Koyama K, Takahashi K, Ono Y, Oyama K, Tamamura N, Tanaka H, et al. Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma. Journal of Gastroenterology. 2026;61(5):660-672. doi:10.1007/s00535-026-02382-9

BibTeX
@article{Koyama2026,
  author = {Koyama, Kazuya and Takahashi, Kenji and Ono, Yusuke and Oyama, Kyohei and Tamamura, Nobue and Tanaka, Hiroki and Asai, Fumi and Kobayashi, Yukino and Maeda, Chiho and Ohtaki, Yu and Sato, Hiroki and Okada, Tetsuhiro and Kawabata, Hidemasa and Iwamoto, Hidetaka and Kitano, Yohei and Itoh, Taito and Matsuda, Akiko and Inuzuka, Tatsutoshi and Taniue, Kenzui and Nakayama, Koh and Fujiya, Mikihiro and Okumura, Toshikatsu and Mizukami, Yusuke},
  title = {Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma},
  journal = {Journal of Gastroenterology},
  year = {2026},
  volume = {61},
  number = {5},
  pages = {660--672},
  doi = {10.1007/s00535-026-02382-9}
}
Kostenlos starten →